Avoro Capital Advisors LLC acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,444,444 shares of the exchange traded fund’s stock, valued at approximately $396,844,000. SPDR […]